A two-year clinical trial found that older adults who ate a handful of walnuts every day ended up with higher levels of a key immune protein than those who did not.
Quick Take
- A randomized trial of 474 older adults found walnut eaters had about 6% higher total IgG, a key infection-fighting antibody, after two years.
- The same trial, called WAHA, also found walnuts lowered six of ten inflammation markers compared to a walnut-free diet.
- Researchers say it’s too early to know if higher IgG actually means fewer infections or stronger vaccine protection.
- A separate short-term study found walnut eating changed gene activity in immune cells tied to vaccine memory.
What The Walnut Trial Actually Found
The study, known as WAHA, followed 708 healthy adults ages 63 to 79 in Barcelona and Loma Linda, California. Researchers randomly split them into two groups for two full years. One group ate roughly 30 to 60 grams of walnuts daily, about 15% of their total calories. The other group avoided walnuts and cut back heavily on other nuts, too.
Blood samples from 474 of those participants showed something notable. The walnut eaters had about 6% higher total IgG than the control group after two years. IgG is the antibody your body relies on most to remember past infections and fight them off faster the next time. The walnut diet also significantly reduced six of ten inflammatory markers researchers tracked.
Why This Isn’t A Free Pass To Call Walnuts A Cure
Not every immune marker moved. The study found no real difference in total IgM, another antibody type, or in antibodies tied to modified LDL cholesterol. That means the walnut effect was narrow, hitting some markers and skipping others entirely. Researchers themselves said more work is needed before anyone claims real protection against disease.
No part of this study tracked whether walnut eaters actually got sick less, went to the hospital less, or lived longer. Higher IgG sounds good on paper, but scientists have not yet connected that specific bump to any real-world health outcome. A caveat worth remembering: an interesting lab result is not the same as a proven health benefit.
A Second Study Points To Genes, Not Just Blood Tests
A separate, shorter study looked at what happens inside immune cells after just three weeks of eating walnuts. Researchers ran RNA sequencing on blood cells and found real changes in gene activity. Some of those genetic shifts overlapped with genes already linked to strong memory B-cell responses, the cells that help your body remember vaccines and past infections.
That overlap is intriguing, but it’s a clue, not proof. Matching gene patterns to ones seen in good vaccine responders does not mean walnuts make vaccines work better. It means scientists have a lead worth chasing with real vaccine-response trials, the kind that measure actual antibody levels after a flu shot or similar vaccine, not just gene activity in a lab.
Keeping The Scope Honest
It’s easy to see “708-person randomized trial” and assume every person contributed to every result. In reality, the immune findings came from a subset of 474 participants, and the people studied were healthy, independent older adults, not frail seniors or people with diagnosed immune problems. That matters for anyone trying to apply these results to a parent in assisted living or a grandparent managing diabetes.
The research also came out of a program built specifically to study walnuts, called the Walnuts and Healthy Aging study. That alone doesn’t discredit the findings, but readers deserve to know the research had a narrow focus from the start. None of this erases the real, measured results. It just means the honest takeaway is “promising lead,” not “proven fix,” and that distinction matters for anyone making health decisions based on a headline.
For now, the science supports something simple and low-risk: a daily handful of walnuts is tied to lower inflammation and a modest rise in one antibody type among healthy older adults. Whether that translates into fewer colds, better vaccine protection, or a longer life is the next question scientists still have to answer.
Sources:
news.llu.edu, publichealth.llu.edu, pmc.ncbi.nlm.nih.gov, jacc.org
